semaglutide gonzales What happens after stopping GLP-1 medications like Ozempic? At MUSC Health, experts say the answer is simple but often misunderstood: weight regain is common because obesity is a chronic disease, not a My Game-Changing Experience: Amanda Gonzales

Ozempic stimulates GLP-1 receptors in the pancreas to increase insulin release after meals and reduce blood sugar levels

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus in adults

PMID: 42 DangBNDuwaRLeeSKwonTKChangJHJeongJHet al

For the sake of preventing information overload, other effects were glossed over but are now worth bringing up here

Laboratory Testing: Checking fasting glucose, A1C, liver and kidney function, and thyroid health to confirm treatment safety

The evidence suggests that for many patients, particularly those with obesity-related liver disease, GLP-1-based weight loss injections may be hepatoprotective rather than harmful